91 Pages | 30 Exhibits | 2016 Analysis | Forecasts Through 2020 Product Family: Market Reports

This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global markets for bone densitometry systems and bone turnover marker tests.


  • Fractures from osteoporosis and low bone mass cost approximately $20bn a year in the US, with this figure expected to grow to approximately $25bn by 2025.
  • The estimated cost of osteoporosis in the EU is approximately €37bn [$44.3bn] annually, with fractures accounting for 66% of costs.
  • The combined global market for osteoporosis diagnostic products totalled approximately $253.0 million in 2015, and is expected to climb at a rate of 3.8% over the forecast period.
  • Dual-energy X-ray densitometers account for the largest segment of the global market for bone densitometry equipment.
Key Questions Answered
  • What are the key drivers and limiters to the global market for osteoporosis diagnostic products?
  • Which competitors are leading the market and introducing new technology?
  • How are technological advancements impacting market growth?
  • Which areas of the market are experiencing the greatest growth?
  • How are mergers and acquisitions affecting the marekt shares of leading competitors?


i. Methodology 

Exhibit ES-1: Global osteoporosis diagnostic products, combined market forecast, 2015-2020 
Exhibit ES-2: Global osteoporosis diagnostic products market, share by product type, 2015 

1.1 Prevalence and Cost 
1.2 Fracture Incidence and Economic Costs 
1.3 Types of Osteoporosis 
1.4 Risk Factors 
1.5 Treatment 
1.6 Bibliography 

Exhibit 1-1: Normal bone and osteoporotic bone 
Exhibit 1-2: Osteoporosis prevalence across the US, Japan, and 5EU, 2015-30 
Exhibit 1-3: Osteopenia prevalence across the US, Japan, and 5EU, 2015-30 
Exhibit 1-4: Osteoporosis-caused fracture incidence in the EU, by site 
Exhibit 1-5: US hospitalizations for fragility fractures in women, by site 
Exhibit 1-6: Types of osteoporosis 
Exhibit 1-7: Leading risk factors for osteoporosis 
Exhibit 1-8: Population growth of 65+ years age group, 2000-50, selected countries.

2.1 Bone Densitometry Overview 
	2.1.1 Dual-energy X-ray absorptiometry 
	2.1.2 Single-energy X-ray absorptiometry 
	2.1.3 Radiographic absorptiometry 
	2.1.4 Quantitative computed tomography 
	2.1.5 Quantitative ultrasound 
	2.1.6 Software-based densitometry systems 
	2.1.7 Hospital-based densitometry systems 
	2.1.8 Office-based densitometry systems 
2.2 Bone Densitometry Products 
	2.2.1 BeamMed 
	2.2.2 CompuMed 
	2.2.3 Furuno Electric Company 
	2.2.4 GE Healthcare/General Electric Company 
	2.2.5 Hologic 
	2.2.6 Swissray 
	2.2.7 Emerging 
2.3 Market Analysis 
	2.3.1 Market forecast: US Insurance reimbursement 
	2.3.2 Market forecast: EU DXA utilization Insurance reimbursement 
	2.3.3 Market forecast: Japan 
	2.3.4 Market forecast: rest of the world 
	2.3.5 Competitive analysis: global Competitive analysis: US Competitive analysis: EU Competitive analysis: rest of the world 
	2.3.6 Detailed analysis, by competitor GE Healthcare/General Electric Company Hologic 
2.4 Bibliography 

Exhibit 2-1: Comparison of biochemical markers and bone densitometry as tools for diagnosing and monitoring osteoporosis 
Exhibit 2-2: Imaging modalities used to diagnose osteoporosis 
Exhibit 2-3: Selected bone densitometry systems 
Exhibit 2-4: BeamMed's Sunlight Omnisense 9000 bone sonometer 
Exhibit 2-5: The Norland family of dual-energy X-ray absorptiometry systems 
Exhibit 2-6: GE's Lunar iDXA dual-energy X-ray absorptiometry system 
Exhibit 2-7: The Discovery and Horizon dual-energy X-ray absorptiometry systems 
Exhibit 2-8: The OsteoGram radiographic absorptiometry system 
Exhibit 2-9: The CM-200 quantitative ultrasound bone densitometry system 
Exhibit 2-10: Bone densitometry systems market forecast, by region, 2015-20
Exhibit 2-11: Spending on healthcare in the US and selected European countries 
Exhibit 2-12: Bone densitometry systems global market, share by supplier, 2015 
Exhibit 2-13: Bone densitometry systems US market, share by supplier, 2015 
Exhibit 2-14: Bone densitometry systems EU market, share by supplier, 2015 
Exhibit 2-15: Bone densitometry systems RoW market, share by supplier, 2015 

3.1 Biochemical Markers Overview 
	3.1.1 Types of bone turnover markers 
	3.1.2 Applications 
	3.1.3 Limitations 
3.2 Biochemical Marker Testing Products 
	3.2.1 Alere 
	3.2.2 Beckman Coulter/Danaher 
	3.2.3 Immunodiagnostic Systems 
	3.2.4 Orion Diagnostica/Orion Group
	3.2.5 Quest Diagnostics 
	3.2.6 Quidel 
	3.2.7 Roche Diagnostics/F Hoffmann-La Roche 
3.3 Reimbursement 
3.4 Market Analysis 
3.5 Competitive Analysis 
	3.5.1 Detailed analysis, by competitor Alere Quidel Roche Diagnostics/F Hoffmann-La Roche 
3.6 Bibliography 

Exhibit 3-1: The bone remodeling cycle 
Exhibit 3-2: Comparison of selected bone remodeling biochemical marker tests 
Exhibit 3-3: Selected bone remodeling biochemical marker tests 
Exhibit 3-4: Bone remodeling biochemical marker tests market forecast, by region, 2015-20
Exhibit 3-5: Bone remodeling biochemical marker tests global market, share by supplier, 2015 



  1. Alere, Inc.
  2. Artann Laboratories
  3. BeamMed LTD
  4. Beckman Coulter, Inc.
  5. CompuMed, Inc.
  6. Diagnostic Medical Systems
  7. Furuno Electric Company LTD
  8. GE Healthcare/ General Electric Company
  9. Hitachi Medical Systems, Inc.
  10. Hologic, Inc.
  11. Immunodiagnostic Systems Holdings PLC
  12. Orion Diagnostica Oy/Orion Corporation
  13. Osteometer Meditech, Inc.
  14. Quest Diagnostics, Inc.
  15. Quidel Corporation
  16. Roche Holding AG/Roche Group
  17. Sectra AB
  18. Swissray Medical AG/Swissray Global Healthcare
Contact Us

Need help finding medtech research? Let us help you!